Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety and efficacy of insulin aspart versus insulin lispro in insulin pumps in children and adolescents with type 1 diabetes

Trial Profile

Safety and efficacy of insulin aspart versus insulin lispro in insulin pumps in children and adolescents with type 1 diabetes

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Dec 2016

At a glance

  • Drugs Insulin aspart; Insulin lispro
  • Indications Type 1 diabetes mellitus
  • Focus Registrational; Therapeutic Use
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 20 May 2009 Actual end date (May 2006) added as reported by ClinicalTrials.gov.
    • 01 Feb 2008 Efficacy and tolerability results have been published.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top